Status:
RECRUITING
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
Lead Sponsor:
Thomas Jefferson University
Collaborating Sponsors:
Sidney Kimmel Cancer Center at Thomas Jefferson University
Conditions:
Type 2 Diabetes Mellitus (T2DM)
Pregnancy
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare patient adherence to blood sugar monitoring during pregnancy using two different measurement methods in pregnancies complicated by pregestational type 2 diabete...
Detailed Description
About 1-2% of pregnant patients in the United States have pregestational type 2 diabetes (T2DM). The current standard of care for patients needing pharmacotherapy is to initiate basal and postprandial...
Eligibility Criteria
Inclusion
- singleton pregnancies
- fetuses without anomalies
- diagnosis of Type 2 diabetes
- initiation of prenatal care at \<20 weeks gestation
Exclusion
- diagnosis of Type 1 diabetes
- allergy to insulin
- inability to wear a continuous glucose monitor
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT07184775
Start Date
October 1 2025
End Date
March 1 2026
Last Update
October 14 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Jefferson Health New Jersey
Sewell, New Jersey, United States, 08080
2
Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107